USE OF GABEXATE MESYLATE AND ULINASTATIN FOR THE PREVENTION OF POST-ERCP PANCREATITIS AND RISK FACTOR ANALYSIS

(1) Eulji University Hospital, Dept. of Internal Medicine, Daejeon, Republic of Korea

(2) Internal Medicine, EULJIUNIVERSITY HOSPITAL, Daejeon, Korea, Republic Of



This item was part of the Endoscopy and Imaging I session at UEG Week Barcelona 2010

This item can be cited as: Endoscopy 2010; 42 (Suppl I) A156